Cargando…

Early Start Of Tenofovir Treatment Achieves Better Viral Suppression In Pregnant Women With A High HBV Viral Load: A Real-World Prospective Study

PURPOSE: To investigate whether tenofovir disoproxil fumarate (TDF) treatment that started from the second trimester had an advantage over TDF treatment that started from the third trimester. PATIENTS AND METHODS: Twenty 35-year-old pregnant women with hepatitis B virus (HBV) DNA >2×106 IU/mL wer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Fan, Zhang, Wen-Tao, Lin, Ya-Yun, Wang, Wei-Min, Xu, Na, Bai, Gui-Qin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844215/ https://www.ncbi.nlm.nih.gov/pubmed/31807036 http://dx.doi.org/10.2147/IDR.S228982

Ejemplares similares

Efficacy of tenofovir in preventing perinatal transmission of HBV infection in pregnant women with high viral loads
por: Lin, Yayun, et al.
Publicado: (2018)

An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression
por: Das, Srijanee, et al.
Publicado: (2022)

Factors associated with time to achieve an undetectable HIV RNA viral load after start of antiretroviral treatment in HIV-1-infected pregnant women
por: Snippenburg, W, et al.
Publicado: (2017)

Viral suppression and factors associated with failure to achieve viral suppression among pregnant women in South Africa
por: Woldesenbet, Selamawit A., et al.
Publicado: (2020)

Viral Load Reduction Achieved with Mouthrinses
Publicado: (2022)

HBV‐RNA Co‐amplification May Influence HBV DNA Viral Load Determination
por: Maasoumy, Benjamin, et al.
Publicado: (2020)

Multicenter Evaluation of the Cepheid Xpert(®) HBV Viral Load Test
por: Marcuccilli, Fabbio, et al.
Publicado: (2021)

Alteration of the Immune Microenvironment in HBsAg and HBeAg Dual-Positive Pregnant Women Presenting a High HBV Viral Load
por: Gao, Fan, et al.
Publicado: (2021)

Viral load suppression in HIV-infected adolescents in cameroon: towards achieving the UNAIDS 95% viral suppression target
por: Djiyou, Armando B. D., et al.
Publicado: (2023)

Long-Term Outcome of HBV-Infected Patients with Clinically Significant Portal Hypertension Achieving Viral Suppression
por: Jachs, Mathias, et al.
Publicado: (2022)

Effects of Interferon-α/β on HBV Replication Determined by Viral Load
por: Tian, Yongjun, et al.
Publicado: (2011)

Prophylactic effect of tenofovir on viral reactivation in immunocompromised pregnant women living with hepatitis B virus
por: Zhang, Le, et al.
Publicado: (2022)

Suppression of HBV by Tenofovir in HBV/HIV Coinfected Patients: A Systematic Review and Meta-Analysis
por: Price, Huw, et al.
Publicado: (2013)

Real-world impact of switching from tenofovir disoproxil fumarate to tenofovir alafenamide
por: Michienzi, Sarah M, et al.
Publicado: (2021)

Time to Viral Suppression in Perinatally HIV-Infected Infants Depends on the Viral Load and CD4 T-Cell Percentage at the Start of Treatment
por: Schröter, Juliane, et al.
Publicado: (2020)

HBV-HCV Coinfection: Viral Interactions, Management, and Viral Reactivation
por: Mavilia, Marianna G., et al.
Publicado: (2018)

1040. Real-World Implementation of Dolutegravir-Lamivudine to Achieve and Maintain HIV-1 Viral Suppression at an Academic Medical Center
por: Hiryak, Kayla, et al.
Publicado: (2020)

Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study
por: Wang, Tingyan, et al.
Publicado: (2021)

Intermittent Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment Maintains High Level of Viral Suppression in Virally Suppressed People Living with HIV
por: Sellem, Baptiste, et al.
Publicado: (2023)

HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons
por: Bihl, Florian, et al.
Publicado: (2015)

Bone outcomes in virally suppressed youth with HIV switching to tenofovir disoproxil fumarate
por: Braithwaite, Kate, et al.
Publicado: (2021)

Recycling tenofovir in second-line antiretroviral treatment with dolutegravir: outcomes and viral load trajectories to 72 weeks
por: Keene, Claire M, et al.
Publicado: (2023)

Atorvastatin Rapidly Reduces Hepatitis B Viral Load in Combination with Tenofovir: A Prospective Clinical Trial
por: Gharehbeglou, M., et al.
Publicado: (2022)

Viral Load Affects the Immune Response to HBV in Mice With Humanized Immune System and Liver
por: Dusséaux, Mathilde, et al.
Publicado: (2017)

Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load
por: Gordon, Stuart C, et al.
Publicado: (2013)

Efficacy and safety of tenofovir disoproxil fumarate in preventing vertical transmission of hepatitis B in pregnancies with high viral load
por: Chen, Jun-Ze, et al.
Publicado: (2017)

HBV/HCV dual infection impacts viral load, antibody response, and cytokine expression differently from HBV or HCV single infection
por: Chen, Fei, et al.
Publicado: (2016)

Hepatitis B Virus (HBV) Genotype Mixtures, Viral Load, and Liver Damage in HBV Patients Co-infected With Human Immunodeficiency Virus
por: Jose-Abrego, Alexis, et al.
Publicado: (2021)

3-year Treatment of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate for Chronic HBV Infection in China
por: Hou, Jinlin, et al.
Publicado: (2021)

Viral integration drives multifocal HCC during the occult HBV infection
por: Chen, Xiao-Ping, et al.
Publicado: (2019)

Effects of viral load on tenofovir vs. entecavir efficacy in recurrence prevention of hepatitis B virus-related hepatocellular carcinoma
por: Qi, Weili, et al.
Publicado: (2023)

Viral Blips Were Infrequent in HIV-1-Infected Virologically-Suppressed Adults Treated with Tenofovir Alafenamide or Tenofovir DF Rilpivirine-Containing Regimens
por: Wohl, David A, et al.
Publicado: (2017)

Renal safety of tenofovir and/or entecavir in patients with chronic HBV monoinfection
por: Yang, Young-Mo, et al.
Publicado: (2017)

Effectiveness of tenofovir or telbivudine in preventing HBV vertical transmission for pregnancy
por: Zeng, Jianyong, et al.
Publicado: (2019)

Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in The Gambia
por: Mendy, Maimuna E, et al.
Publicado: (2008)

Genotypes, mutations, and viral load of hepatitis B virus and the risk of hepatocellular carcinoma: HBV properties and hepatocarcinogenesis
por: Zhang, Qi, et al.
Publicado: (2011)

HBV Viral Load and Liver Enzyme Levels May Be Associated with the Wild MBL2 AA Genotype
por: Moura, Tuane Carolina Ferreira, et al.
Publicado: (2017)

Get rich slow: start now, start small, achieve real wealth
por: Riegelhuth, Sarah
Publicado: (2013)

Switching Tenofovir/Emtricitabine plus Lopinavir/r to Raltegravir plus Darunavir/r in Patients with Suppressed Viral Load Did Not Result in Improvement of Renal Function but Could Sustain Viral Suppression: A Randomized Multicenter Trial
por: Nishijima, Takeshi, et al.
Publicado: (2013)

Correction to: Viral integration drives multifocal HCC during the occult HBV infection
por: Chen, Xiao-Ping, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0bo43767to6jet20lgn0p3ml57